GlassScriptPhysician profile
Swaroop Reddy
NPI 1235363581
$1,841.02
in general payments reported to CMS, 2019-2025
14 companies · $28.26 in 2025
The $28.26 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $205 · 2021: $555 · 2022: $385 · 2023: $464 · 2025: $28.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $491.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $422.42 | 2020-2025 | Caplyta |
| Alkermes, INC. | $356.83 | 2019-2023 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $291.12 | 2019-2023 | Ingrezza |
| Abbvie INC. | $262.84 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $163.95 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $159.19 | 2019-2023 | Invega Sustenna |
| Lundbeck LLC | $59.12 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $25.47 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $24.66 | 2019-2020 | |
| Corium, LLC | $21.60 | 2022 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $19.10 | 2019 | |
| Adlon Therapeutics L.P. | $14.30 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.78 | 2019 | |
| Brainsway USA INC | $8.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Swaroop Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.